overview of cryptocurrency Top

Modern Investment: Xu Qing, the independent director of the company, was subject to disciplinary review and supervision investigation. According to the announcement of Modern Investment, Xu Qing, the independent director of the company, was suspected of serious violation of discipline and law, and is currently subject to disciplinary review by the Disciplinary Committee of Hunan Branch of Industrial and Commercial Bank of China and supervision investigation by Zhuzhou Municipal Supervision Committee. Xu Qing did not hold any other positions in the company except as an independent director, chairman of the Nomination Committee of the Board of Directors, member of the Strategy Committee of the Board of Directors and member of the Audit Committee of the Board of Directors, and did not participate in the daily operation and management of the company. The company will pay attention to the subsequent progress and fulfill its information disclosure obligations in a timely manner in strict accordance with relevant regulations.HSBC is studying plans to cut costs by at least $3 billion. On December 11th, it was reported that HSBC Holdings was studying plans to cut costs by at least $3 billion. According to people familiar with the matter, HSBC told managers last week that its reform would not be completed until June 2025. These people said that the total cost savings are still in progress, but executives hope that this work will help them reduce their expenses by at least $3 billion.Guanghua Technology: Breaking the dependence on the import of key raw materials for daily chemicals and meeting the high-end diversified needs. In the global oral care industry, tin salt is a key raw material, which is widely used in toothpaste and professional oral care products because of its excellent effects of preventing dental caries, anti-sensitivity, reducing gingival bleeding and fighting gingivitis. However, the domestic market has long relied on imports for this key raw material, and the production cost remains high, which seriously restricts the competitiveness of our oral care products in the international market. Guanghua Technology has made a breakthrough in this field, successfully breaking the long-term dependence on imports, taking the lead in becoming a domestic enterprise to realize large-scale production of this special effect ingredient, significantly reducing the cost of key raw materials for customers, and further enhancing the competitiveness of China manufacturing in the international market.

Sources: Thailand's Cabinet approves the draft of the lowest corporate tax law in the world.Market News: Apple is cooperating with Broadcom around artificial intelligence (AI) chips. Apple chips may be ready for production in 2026.ADB approved a loan of US$ 200 million for power infrastructure construction in Pakistan.

Macy's fell 8.2% before the market, and the company lowered its profit outlook after discovering accounting errors.Guanghua Technology: Breaking the dependence on the import of key raw materials for daily chemicals and meeting the high-end diversified needs. In the global oral care industry, tin salt is a key raw material, which is widely used in toothpaste and professional oral care products because of its excellent effects of preventing dental caries, anti-sensitivity, reducing gingival bleeding and fighting gingivitis. However, the domestic market has long relied on imports for this key raw material, and the production cost remains high, which seriously restricts the competitiveness of our oral care products in the international market. Guanghua Technology has made a breakthrough in this field, successfully breaking the long-term dependence on imports, taking the lead in becoming a domestic enterprise to realize large-scale production of this special effect ingredient, significantly reducing the cost of key raw materials for customers, and further enhancing the competitiveness of China manufacturing in the international market.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)